Innovative Medicines Canada

7 articles about Innovative Medicines Canada

• 

  Canada Urges Industry to Prepare for U.S. Drug Import Changes

  8/5/2019

  Canada’s primary pharmaceutical lobby group, Innovative Medicines Canada, urged the Canadian government to respond to the U.S. plans before it caused drug shortages in Canada. An earlier version of its briefing called for a government ban of all drug exports “unless otherwise permitted by regulat...

• Fiscal update 2018: Innovative Medicines Canada welcomes renewed commitment to competitiveness

  11/21/2018

  The following statement can be attributed to Innovative Medicines Canada President, Pamela Fralick.

• Innovative Medicines Canada Welcomes ISED Roundtable Recommendations for Health & Biosciences Sector

  9/25/2018

  Innovative Medicines Canada (IMC) welcomes the recommendations made by the Government of Canada's Health/Biosciences Economic Strategy Table (HBEST) Report released today.

• Innovative Medicines Canada applauds the changes to OHIP+

  7/3/2018

  Innovative Medicines Canada congratulates the new Ontario Minister of Health and Long-Term Care, Christine Elliott, on moving decisively to revamp OHIP+.

• Statement - National Pharmacare should ensure access to medicines for all

  4/19/2018

  The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada.

• Ontario budget 2018-19: Innovative Medicines Canada commends commitments on improving drug access

  3/29/2018

  In response to the budget tabled by Ontario Finance Minister Charles Sousa, Innovative Medicines Canada welcomes the creation of the Ontario Drug and Dental Program and the expansion of OHIP + to seniors.

• Innovative Medicines Canada Welcomes Akcea Therapeutics Canada And Ipsen Biopharmaceuticals Canada As Its Newest Members

  9/5/2017